Background Abstraction
Anxiety disorders are among the most prevalent mental health issues. This study looked at the burden of anxiety disorders during the previous three decades on a worldwide and regional scale. The purpose of the study was to identify high-risk populations and trends in order to better precisely target management and preventative actions. The most recent Global Burden of Disease dataset's epidemiological data on anxiety disorders were examined to calculate the rates of disability-adjusted life years (DALYs) for 204 countries and regions from 1990 to 2019.
Outcomes
It is estimated that 301 million individuals, or 4.05% of the world's population, suffer from an anxiety illness. Between 1990 and 2019, there was a more than 55% rise in the total population impacted. Metrics for anxiety disorders indicate that rates of DALYs, incidence, and prevalence are always rising. With 8,671 occurrences per 100,000, Portugal has the highest prevalence, followed by Brazil, Iran, and New Zealand. In areas with higher incomes, the prevalence is higher. Anxiety problems affect women 1.66 times more frequently than they do men. The stability of age-standardized rates suggests that risk factors may also be steady.
In conclusion
Over the past thirty years, anxiety problems have become more common. Urbanization, a more reliant older population, and socioeconomic progress all seem to be associated with an increase in the prevalence of anxiety. Prospective investigations on this subject matter may encompass the creation of more precise cross-cultural measures to evaluate anxiety and its associated factors, in addition to population-based analyses to evaluate patterns in anxiety across time.
Context
Anxiety disorders are biopsychosocial problems linked to responses to perceived threats that might be situation-specific or generalized. In the past, there has been a lot of research interest in the prevalence of anxiety. Among the most prevalent mental illnesses are anxiety disorders. Though they typically manifest early in infancy, they have a major functional impact, a purposefully persistent progression, and similarities with other mental diseases. The well-being and quality of life of the populace are seriously threatened by an increase in the incidence of anxiety worldwide. Anxiety disorders present with various clinical symptoms. Some people get phobias as a result of certain environmental triggers. Others might suffer from intense, sporadic distress, similar to panic disorder. The fight-or-flight response is triggered by these events when it is interpreted as a threat by the prefrontal cortex and the amygdala. This response might take the shape of psychophysiological symptoms as perspiration, lightheadedness, and elevated heart rate. Chronic anxiety can lead to a host of additional health problems, including dementia, cardiovascular disease, and hypertension, if treatment is not received. Anxiety is currently treated with a combination of medication and psychotherapy. Pharmacological interventions can address the physiological reaction linked to anxiety, but psychological interventions are necessary to address the psychological triggers and memories that give rise to fear. Numerous studies indicate that cognitive behavioral therapy and other psychotherapies are more useful to those with anxiety disorders over the long term. To better target preventive and therapeutic efforts throughout the community and detect trends related to demographic factors, researchers must comprehend the epidemiological character of anxiety.
Understanding population patterns, such as whether anxiety is rising or falling, variables linked to shifting trends, and elements in the regulation and treatment of anxiety disorders, depend heavily on disease epidemiology. The wide variations in prevalence rates across the globe may indicate a variation in the distribution of risk factors for certain conditions. However, the development of diagnostic criteria throughout time and methodological and cultural factors likely have a significant impact. The global epidemiological evidence linked to anxiety disorder has not, as of yet, been synthesized, despite the availability of epidemiological data for many nations. Information about the true frequency and causative causes of anxiety disorders may be misrepresented due to variations in the reporting and documenting of anxiety across international borders. In order to assess population-wide trends and potential anxiety-causing factors, as well as to more effectively target health promotion efforts to lessen the financial and social burden associated with this mental health issue, a thorough epidemiological study of the global burden of anxiety disorders and their socio demographic associations is required.
This study sought to assess the regional and global burden of anxiety disorders based on gaps in the literature related to the epidemiology of anxiety. Based on patterns found in the epidemiological data, a forecast and trend analysis for anxiety disorders was also provided. This study's evaluation of annual changes in anxiety disorders using age-standardized rates—which were utilized to account for the impact of an aging population—was one of its most distinctive contributions.
Techniques
Source of data
Prevalence, incidence, and mortality rates linked to anxiety disorders at the international, regional, and national levels were the inclusion criteria for the data. Clinic-based records and other subnational data were included in the exclusion criteria. Health indicators related to anxiety disorders were taken from the Global Burden of Disease (GBD) dataset.
Additionally, each country's Social Development Index (SDI), which is a gauge of social and human development, is provided by GBD. The SDI, which goes from 0 to 1, is a composite of three factors: income, total fertility rate, and education. The GBD dataset's resilience can be attributed to its extensive dependence on several sources, including government reports, healthcare registries, independent studies, vital registration, and census-related data.GBD has been utilized in epidemiological studies for many illnesses, such as dementia, and generates trustworthy estimates of health indicators. In order to resolve data sampling problems such as missing data and differences in the case definition, modeling adjustments are used to verify the data reliability. The Guidelines for Accurate and Transparent Health Estimates Reporting were followed in the course of this study.
We also gathered further demographic data from the World Bank Databank. These included GDP per capita, the proportion of the working-age population that is dependent on the older population (age dependency), the percentage of the population that lives in urban areas relative to the overall population (urbanization), and the percentage of the labor force that is unemployed. Our World in Data included information on per capita alcohol use, economic inequality, and literacy.
variables in the data
Anxiety disorder prevalence, incidence, and disability-adjusted life years (DALYs) were examined. The years of life lost to early death and the years spent with a handicap are combined to form DALY. Utilizing the GBD Results tool, data pertaining to anxiety disorders was acquired. The data visualization tool that was used was the GBD Compare tool. Anxiety disorders are under the Mental Disorders category of GBD.
Data interpretation
Using GAD analytical tools, which include visualization, we examined the data. The highest fidelity was attained with the use of these tools. The frequency and incidence of anxiety disorders were examined both in its raw and age-adjusted forms. aging-standardized rates eliminate the impact of population aging over time, across regions, and across national borders, allowing conclusions about inherent changes in the burden of anxiety disorders. The age at which anxiety disorders first manifested itself was assessed using age-specific incidence rates. By comparing data over the previous three decades, the scientists sought to determine whether the age of onset was declining over time.
Analytical statistics
Bivariate correlations, temporal trends, and summary statistics were examined in the data. Multiple linear regression was used for multivariate analysis. The variables' multicollinearity and normality were examined. Jamovi statistical software was used for data analysis. No imputation was made for missing data. A statistical significance level of 0.05 was applied to the alpha level.
Outcomes
occurrence
The burden of anxiety disorders which are treatable in particular nations and regions is shown by the uncertainty interval, which indicates the global prevalence of anxiety disorders in 2019 was 4.05%. Between 1990 and 2019, the total number of affected people grew significantly, from 194.9 million to 301.4 million worldwide. 12,537 cases of mental health disorders per 100,000 people was the global prevalence rate. 3,895 cases of anxiety disorders were reported for every 100,000 people. The prevalence of anxiety disorders was much higher than that of other major mental health problems. For example, there were 511 cases of bipolar disorder and 304 cases of schizophrenia per 100,000 people.
Age of commencement
Surprisingly, the age distribution of newly diagnosed cases revealed an incidence that began at age ten. The ages of 10 to 14 and 35 to 39 saw two distinct modal peaks. After 65 years of age, the incidence of new cases starts to decrease. Nonetheless, the elderly continue to have a high frequency. Over the past three decades, there has been no change in the age distribution of new cases or the prevalence of anxiety disorders.
No comments yet